The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHSTN.L Regulatory News (HSTN)

  • There is currently no data for HSTN

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Director/PDMR Shareholding

17 Oct 2017 16:39

RNS Number : 8645T
Hansteen Holdings plc
17 October 2017
 

 

17 October 2017

 

Hansteen Holdings PLC

("Hansteen" or the "Company")

 

Notification of Transactions of Directors, Persons Discharging Managerial Responsibilities ("PDMRs") and persons closely associated with them

 

On 16 October 2017, the directors of the Company listed below exercised their vested Performance Share Plan nil cost options (i.e. no exercise price is payable when the options are exercised) pursuant to the Rules of the Performance Share Plan 2012. The awards vested between 11 June 2014 and 11 June 2017 and were subject to achievement of the following performance conditions measured over a three year performance period:

· 50% of the award will vest by reference to the Company's Total Shareholder Return over the performance period ranking relative to a Comparator Group of Real Estate Investment Trusts approved by the Remuneration Committee; and

· 50% of the award will vest by reference to the Company's EPRA Net Asset Value per share growth from investing in the Company over the performance period ranking relative to the same Comparator Group.

No consideration is due on these options upon exercise.

Name

Director/ PDMR

Number of shares awarded on PSP 1 award 9 July 2012 and exercisable

Number of shares awarded on PSP 2 award 9 July 2012 and exercisable

Number of shares awarded on PSP 3 award 28 March 2013 and exercisable

Number of shares awarded on PSP 4 award 10 April 2014 and exercisable

Number of shares awarded attributable to dividends payable over the period from grant to exercise

Total shares awarded and exercisable including shares attributable to dividends

 

Shares sold to cover tax and National Insurance Contributions and dealing costs at a share price of 135.15p

Shares retained by individual

Morgan Jones

Director

218,694

194,395

86,907

47,074

121,087

668,157

316,707

351,450

Ian Richard Watson

Director

218,694

194,395

86,907

47,074

121,087

668,157

316,707

351,450

Richard Philip Lowes

Director

142,152

126,357

55,005

29,775

78,237

431,526

204,544

226,982

 

The notification below, which has been made in accordance with the requirements of the EU Market Abuse Regulation, provides further detail.

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them

 

 

1

Details of the person discharging managerial responsibilities/person closely associated

a)

Name

Ian Watson

2

Reason for the notification

a)

Position/status

Chief Executive Officer - Director

b)

Initial notification/Amendment

Initial Notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Hansteen Holdings PLC

b)

LEI

2138007274QQL9KBWY58

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

Identification code

Ordinary shares of £0.10 each in the capital of Hansteen Holdings PLC

GB00B0PPFY88

b)

Nature of transaction

1. Exercise of options over 668,157 Ordinary Shares pursuant to Hansteen Holdings PLC Performance Share Plan 2012

2. Sale of 316,707 shares to cover tax, NI contribution and dealing costs. The balance of 351,450 shares retained.

c)

 

Price(s) and volume(s)

 

Price(s)

Volume(s)

1. nil

1. 668,157

2. 135.15p

2. 316,707

d)

Aggregated information

- Aggregated volume

- Price

Price

Volume

Total

1 nil

1 668,157

1 nil

2 135.15p

2 316,707

2 £428,029.51

e)

Date of the transaction

16 October 2017

f)

Place of the transaction

London Stock Exchange

 

1

Details of the person discharging managerial responsibilities/person closely associated

a)

Name

Morgan Jones

2

Reason for the notification

a)

Position/status

Chief Executive Officer - Director

b)

Initial notification/Amendment

Initial Notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Hansteen Holdings PLC

b)

LEI

2138007274QQL9KBWY58

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

Identification code

Ordinary shares of £0.10 each in the capital of Hansteen Holdings PLC

 GB00B0PPFY88

b)

Nature of transaction

1 Exercise of options over 668,157 Ordinary Shares pursuant to Hansteen Holdings PLC Performance Share Plan 2012

2 Sale of 316,707 shares to cover tax, NI contribution and dealing costs. The balance of 351,450 shares retained.

c)

 

Price(s) and volume(s)

 

Price(s)

Volume(s)

1. nil

1. 668,157

2. 135.15p

2. 316,707

d)

Aggregated information

- Aggregated volume

- Price

Price

Volume

Total

1 nil

1 668,157

1 nil

2 135.15p

2 316,707

2 £428,029.51

e)

Date of the transaction

16 October 2017

f)

Place of the transaction

London Stock Exchange

 

1

Details of the person discharging managerial responsibilities/person closely associated

a)

Name

Richard Lowes

2

Reason for the notification

a)

Position/status

Finance Director

b)

Initial notification/Amendment

Initial Notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Hansteen Holdings PLC

b)

LEI

2138007274QQL9KBWY58

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

Identification code

Ordinary shares of £0.10 each in the capital of Hansteen Holdings PLC

GB00B0PPFY88

b)

Nature of transaction

1 Exercise of options over 431,526 Ordinary Shares pursuant to Hansteen Holdings PLC Performance Share Plan 2012

2 Sale of 204,544 shares to cover tax, NI contribution and dealing costs. The balance of 226,982 shares retained.

c)

 

Price(s) and volume(s)

 

Price(s)

Volume(s)

1. nil

1. 431,526

2. 135.15p

2. 204,544

d)

Aggregated information

- Aggregated volume

- Price

Price

Volume

Price

1 nil

1 431,526

1 nil

2 135.15p

2 204,544

2 £276,441.22

e)

Date of the transaction

16 October 2017

f)

Place of the transaction

London Stock Exchange

 

 

For further information:

Karen Rowe

Capita Company Secretarial Services Limited

+44 (0)20 7954 9569

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
DSHLLFVEIDLDLID
Date   Source Headline
6th Feb 20209:30 amRNSScheme of Arrangement becomes effective
5th Feb 20203:20 pmRNSForm 8.3 - Hansteen Holdings plc
5th Feb 20203:17 pmRNSForm 8.3 - Hansteen Holdings PLC
5th Feb 20202:25 pmRNSForm 8.3 - Hansteen Holdings plc
5th Feb 20201:55 pmRNSHolding(s) in Company
5th Feb 20201:45 pmRNSForm 8.3 - [Hansteen Holdings plc]
5th Feb 202012:21 pmRNSForm 8.3 - Hansteen Holdings plc
5th Feb 202012:11 pmRNSForm 8.5 (EPT/RI) - Hansteen Holdings Plc
5th Feb 202010:30 amRNSIssue of Equity and Director/PDMR Shareholding
5th Feb 202010:26 amRNSForm 8 (DD) - Hansteen Holdings PLC
5th Feb 202010:25 amRNSRule 2.9 Announcement
5th Feb 202010:25 amRNSForm 8 (DD) -Hansteen Holdings PLC
5th Feb 202010:25 amRNSForm 8 (DD) - Hansteen Holdings PLC
5th Feb 20207:30 amRNSSuspension of Listing & Trading in Hansteen Shares
4th Feb 20203:20 pmRNSForm 8.3 - Hansteen Holdings plc
4th Feb 20202:28 pmEQSForm 8.3 - The Vanguard Group, Inc.: Hansteen Holdings plc
4th Feb 20202:25 pmRNSCourt Sanction of the Scheme
4th Feb 20201:36 pmRNSForm 8.3 - Hansteen Holdings plc
4th Feb 202012:41 pmRNSForm 8.3 - Hansteen Holdings plc
4th Feb 202011:25 amRNSForm 8.3 - Hansteen Holdings PLC
4th Feb 202011:18 amRNSForm 8.3 - Hansteen Holdings Plc
4th Feb 202010:56 amRNSForm 8.3 - Hansteen Holdings Plc
4th Feb 20209:09 amRNSForm 8.3 - HANSTEEN HOLDINGS PLC
4th Feb 20209:05 amRNSForm 8.3 - HANSTEEN HOLDINGS PLC
4th Feb 20208:21 amRNSChange to Time of Court Hearing
3rd Feb 20203:34 pmRNSForm 8.3 - Hansteen Holdings plc
3rd Feb 20203:20 pmRNSForm 8.3 - Hansteen Holdings plc
3rd Feb 20203:17 pmRNSForm 8.3 -Hansteen Holdings PLC
3rd Feb 20202:07 pmEQSForm 8.3 - The Vanguard Group, Inc.: Hansteen Holdings plc
3rd Feb 20202:04 pmRNSForm 8.3 - Hansteen Holdings plc
3rd Feb 202012:18 pmRNSForm 8.3 - Hansteen Holdings plc
3rd Feb 202012:17 pmRNSForm 8.3 - Hansteen Holdings plc
3rd Feb 202011:17 amRNSForm 8.3 - Hansteen Holdings Plc
3rd Feb 202010:45 amRNSForm 8.3 - HANSTEEN HOLDINGS PLC - Replacement
3rd Feb 202010:04 amRNSForm 8.3 - Hansteen Holdings PLC
3rd Feb 20208:57 amRNSForm 8.3 - HANSTEEN HOLDINGS PLC
31st Jan 20205:30 pmRNSHansteen Holdings
31st Jan 20203:20 pmRNSForm 8.3 - Hansteen Holdings plc
31st Jan 20202:32 pmRNSRecommended Cash Acquisition
31st Jan 20201:45 pmRNSForm 8.3 - [Hansteen Holdings plc]
31st Jan 20201:43 pmRNSForm 8.3 - Hansteen Holdings plc
31st Jan 20201:28 pmRNSForm 8.3 - Hansteen Holdings Plc
31st Jan 202011:30 amRNSForm 8.3 - Hansteen Holdings plc
30th Jan 20203:20 pmRNSForm 8.3 - Hansteen Holdings plc
30th Jan 20203:16 pmRNSForm 8.3 - Hansteen Holdings PLC
30th Jan 20201:33 pmRNSForm 8.3 - Hansteen Holdings plc
30th Jan 20201:18 pmEQSForm 8.3 - The Vanguard Group, Inc.: Hansteen Holdings plc
30th Jan 202012:18 pmRNSForm 8.3 - Hansteen Holdings Plc
30th Jan 202011:44 amRNSForm 8.3 - Hansteen Holdings plc
30th Jan 202011:21 amRNSForm 8.3 - Hansteen Holdings Plc

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.